项目 | 观察组 | 对照组 |
年龄(岁) | 57.08 ± 11.2 | 54.00 ± 11.7 |
性别(男/女) | 19/3 | 22/0 |
ECOG (0/分1分/2分) | 0/5/18 | 0/5/17 |
糖尿病(有/无) | 4/19 | 3/19 |
高血压(有/无) | 1/22 | 3/19 |
乙肝(有/无) | 20/3 | 19/3 |
肝硬化(有/无) | 7/16 | 12/10 |
门脉高压(有/无) | 10/13 | 9/13 |
肿瘤直径( )/cm | 10.07 ± 5.15 | 9.22 ± 3.90 |
门脉癌栓(有/无) | 8/15 | 6/16 |
分期(IIIa/IIIb) | 14/9 | 15/7 |
腹水(有/无) | 3/20 | 2/20 |
肝区疼痛(有/无) | 18/5 | 16/6 |
纳差(有/无) | 20/3 | 18/4 |
乏力(有/无) | 18/5 | 17/5 |
下肢水肿(有/无) | 9/14 | 9/13 |
Child分级(A级/B级) | 20/3 | 19/3 |
AFP (<25/25 - 400/400 - 1000/>1000 ng/ml) | 6/2/2/13 | 5/4/4/9 |
远处转移(有/无) | 3/20 | 4/18 |
TBIL (μmol/L) | 18.53 ± 12.49 | 17.24 ± 6.12 |
ALT (U/L) | 48.17 ± 28.29 | 52.86 ± 27.03 |
AST (U/L) | 83.43 ± 52.09 | 76.68 ± 45.73 |
ALB (g/L) | 40.30 ± 4.75 | 41.51 ± 5.48 |
ALP (U/L) | 226.04 ± 244.17 | 157.14 ± 87.06 |
CRE (μmol/L) | 68.65 ± 14.80 | 68.27 ± 14.33 |
HGB (g/L) | 135.04 ± 18.35 | 139.50 ± 28.49 |
PLT (*10^9/L) | 161.61 ± 71.25 | 125.23 ± 53.83 |
WBC (*10^9/L) | 6.03 ± 2.82 | 5.51 ± 2.36 |
PT (s) | 12.50 ± 1.59 | 13.10 ± 1.40 |